外籍硕士/博士

　山东普洛得邦医药有限公司是深交所上市公司（000739），主营业务包括抗病毒类药物中间体、原料药和制剂的研究、生产和销售，是头孢克肟原料药和中间体全球最大的生产企业，占全球市场份额60%以上。雷迪帕韦丙肝中间体项目填补国内空白。2016年实现主营业务收入4.6亿元，公司是高新技术企业,建有山东省企业技术中心、山东省一企一技术研发中心, 建立了从中间体到原料药、制剂完整的产业链，与辉瑞、默克、诺华、等国际著名药业巨头建立了长期的战略合作关系。
    Shandong Apeloa Tospo Pharmaceutical Co., Ltd. is a listed company at Shenzhen Stock Exchange (000739), engaging in R&D, manufacturing and marketing of advanced intermediates and APIs. It is the biggest manufacturing company for raw materials and intermediates of Cefixime globally, accounts for more than 60% of the international market share. The annual revenue reached 460 million RMB in the year of 2016. Shandong Apeloa Tospo Pharmaceutical Co., Ltd. is a high-technology enterprise, equipped with strong and creative R&D center, established the industry chain from pharmaceutical intermediate, raw material to final dosage procedure. And the company has established good cooperation relationship with many famous pharmaceutical companies, such as Pfizer, Merck, Novatis.